NL8601285A - Farmaceutische preparaten voor nasale toediening. - Google Patents

Farmaceutische preparaten voor nasale toediening. Download PDF

Info

Publication number
NL8601285A
NL8601285A NL8601285A NL8601285A NL8601285A NL 8601285 A NL8601285 A NL 8601285A NL 8601285 A NL8601285 A NL 8601285A NL 8601285 A NL8601285 A NL 8601285A NL 8601285 A NL8601285 A NL 8601285A
Authority
NL
Netherlands
Prior art keywords
insert according
insert
calcitonin
nose
active agent
Prior art date
Application number
NL8601285A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8601285A publication Critical patent/NL8601285A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Otolaryngology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8601285A 1985-06-04 1986-05-21 Farmaceutische preparaten voor nasale toediening. NL8601285A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858514090A GB8514090D0 (en) 1985-06-04 1985-06-04 Organic compounds
GB8514090 1985-06-04

Publications (1)

Publication Number Publication Date
NL8601285A true NL8601285A (nl) 1987-01-02

Family

ID=10580163

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8601285A NL8601285A (nl) 1985-06-04 1986-05-21 Farmaceutische preparaten voor nasale toediening.

Country Status (21)

Country Link
US (1) US4988512A (el)
JP (1) JPS61282320A (el)
KR (1) KR870000066A (el)
AU (1) AU5824786A (el)
BE (1) BE904863A (el)
CH (1) CH668913A5 (el)
DE (1) DE3617728A1 (el)
DK (1) DK259186A (el)
ES (1) ES8801130A1 (el)
FR (1) FR2582511B1 (el)
GB (3) GB8514090D0 (el)
GR (1) GR861422B (el)
HU (1) HU199300B (el)
IL (1) IL78980A0 (el)
IT (1) IT1214683B (el)
LU (1) LU86457A1 (el)
NL (1) NL8601285A (el)
NZ (1) NZ216393A (el)
PT (1) PT82691B (el)
SE (1) SE8602530L (el)
ZA (1) ZA864164B (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH657779A5 (de) * 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
DE3726517A1 (de) * 1986-08-18 1988-03-03 Sandoz Ag Nasale zusammensetzungen, welche octreotid enthalten
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
GB8712176D0 (en) * 1987-05-22 1987-06-24 Cosmas Damian Ltd Drug delivery system
US5690954A (en) * 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
GB8723846D0 (en) * 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
HU222249B1 (hu) * 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
DE4115849A1 (de) * 1991-05-15 1992-11-19 Lohmann Therapie Syst Lts Penetrationsfoerdernde substanz
ATE157010T1 (de) * 1991-05-24 1997-09-15 Amylin Pharmaceuticals Inc Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
DE4140192C2 (de) * 1991-12-05 1996-02-29 Alfatec Pharma Gmbh Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen
EP0621775B1 (de) * 1992-01-17 1997-08-06 ALFATEC-PHARMA GmbH Peptidarzneistoffe enthaltende pellets und ihre herstellung sowie deren verwendung
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
GB9623205D0 (en) * 1996-11-07 1997-01-08 Eurand Int Novel pharmaceutical compositions
EP1061987B1 (en) * 1998-02-13 2006-05-17 Bioniche Life Sciences Inc. Drug delivery system
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6759393B1 (en) 1999-04-12 2004-07-06 Pfizer Inc. Growth hormone and growth hormone releasing hormone compositions
WO2004084859A2 (en) * 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol
EP1737500A1 (en) * 2004-03-26 2007-01-03 The University of Utah Research Foundation Bioresponsive polymer system for delivery of microbicides
US7396936B1 (en) 2004-11-09 2008-07-08 Kemia, Inc. Modulators of calcitonin and amylin receptor activity

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US820948A (en) * 1905-01-23 1906-05-22 Edward Baum Device fot treating the nasal passages.
US3234091A (en) * 1955-07-08 1966-02-08 Ciba Geigy Corp Shaped medicaments and process for their manufacture
DE1617564A1 (de) * 1966-12-03 1971-04-01 Rudolf Kisro Arzneimitteltraeger
DK135268A (el) * 1973-02-09
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4391797A (en) * 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
US4164560A (en) * 1977-01-05 1979-08-14 Folkman Moses J Systems for the controlled release of macromolecules
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
JPS56100714A (en) * 1980-01-16 1981-08-12 Teijin Ltd Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane
JPS576403A (en) * 1980-06-12 1982-01-13 Toshiba Corp Recording and reproducing device
GB2090535B (en) * 1981-01-06 1984-09-19 Osman Mohammad Fekry Medical inserts
JPS5921613A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
FR2537980B1 (fr) * 1982-12-17 1986-12-19 Sandoz Sa Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4591496A (en) * 1984-01-16 1986-05-27 Massachusetts Institute Of Technology Process for making systems for the controlled release of macromolecules

Also Published As

Publication number Publication date
US4988512A (en) 1991-01-29
DK259186A (da) 1986-12-05
GB8613284D0 (en) 1986-07-09
LU86457A1 (fr) 1987-01-13
BE904863A (fr) 1986-12-03
HU199300B (en) 1990-02-28
GB2213377A (en) 1989-08-16
DK259186D0 (da) 1986-06-02
HUT49288A (en) 1989-09-28
AU5824786A (en) 1986-12-11
FR2582511B1 (fr) 1989-05-26
GB2176105A (en) 1986-12-17
FR2582511A1 (fr) 1986-12-05
GR861422B (en) 1986-10-01
GB8514090D0 (en) 1985-07-10
SE8602530D0 (sv) 1986-06-04
ZA864164B (en) 1988-01-27
NZ216393A (en) 1989-08-29
IL78980A0 (en) 1986-09-30
CH668913A5 (de) 1989-02-15
DE3617728A1 (de) 1986-12-04
GB8906584D0 (en) 1989-05-04
ES8801130A1 (es) 1988-01-01
PT82691B (en) 1988-05-03
IT8648098A0 (it) 1986-06-04
IT1214683B (it) 1990-01-18
PT82691A (en) 1986-07-01
GB2176105B (en) 1990-03-07
SE8602530L (sv) 1986-12-05
KR870000066A (ko) 1987-02-16
JPS61282320A (ja) 1986-12-12
ES555676A0 (es) 1988-01-01

Similar Documents

Publication Publication Date Title
NL8601285A (nl) Farmaceutische preparaten voor nasale toediening.
US5514673A (en) Pharmaceutical composition containing lipophilic drugs
US5346701A (en) Transmucosal delivery of macromolecular drugs
RU2493868C2 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ чГР, ДЛЯ ПЕРОРАЛЬНОГО ВВЕДЕНИЯ
US20020197324A1 (en) Delivery of drugs to mucosal surfaces
GB2248550A (en) Nasal pharmaceutical composition
JPH08505364A (ja) カルシトニン含有医薬組成物
GB2193891A (en) Nasal pharmaceutical compositions containing octreotide
Quadir et al. Development and evaluation of nasal formulations of ketorolac
KR20140041686A (ko) 겔 조성물
JPH11505222A (ja) ２〜６時間の活性成分放出期間をもつ上皮小体ホルモンの医薬投与形態
JPH0782171A (ja) 線維芽細胞成長因子含有フィルム製剤
BR112020024399A2 (pt) composição líquida sem água e sistema para administração transmucosal oral de um ingrediente ativo através de uma composição líquida
AT396331B (de) Verfahren zur herstellung einer octreotid enthaltenden pharmazeutischen zusammensetzung
US6350472B1 (en) Method of treating HIV infection with transdermal gel containing mammalian liver extract
JPS6357528A (ja) 新規製剤
Dugger III et al. Immediate-Immediate Release (I2R) Lingual or Buccal Spray Formulations for Transmucosal Delivery of Drug Substances
JP2002527458A (ja) 体組織上に保護フィルム及び／又は薬用フィルムをインサイチュ（ｉｎｓｉｔｕ）形成するための方法及び組成物
JPH0725662B2 (ja) 使用時調製型上皮細胞成長因子含有水性薬剤の安定化方法

Legal Events

Date Code Title Description
BV The patent application has lapsed